Influenza Treatment Market Size, Share & Trends Analysis Report By Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Influenza Treatment Market: Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Treatment Segment
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Objectives
                        1.4.1. Objective - 1
                        1.4.2. Objective - 2
                        1.4.3. Objective - 3
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary Research
                    1.7. Information or Data Analysis
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List of Secondary Sources
                    1.11. List of Abbreviations
Chapter 2. Influenza Treatment Market: Executive Summary
                    2.1. Market Snapshot
                    2.2. Treatment and Route of Administration Snapshot
                    2.3. Distribution Channel Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. Influenza Treatment Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers Analysis
                        3.4.1. Rising new FDA-approved influenza treatment drugs
                        3.4.2. Prevalence of contagious respiratory illness such as influenza
                    3.5. Market Restraint Analysis
                        3.5.1. Complicated conditions associated with influenza treatment
                    3.6. Porter’s Five Forces Analysis
                    3.7. PESTLE Analysis
Chapter 4. Influenza Treatment Market: Treatment Estimates & Trend Analysis
                    4.1. Influenza Treatment Market: Treatment Movement Analysis
                    4.2. Peramivir
                        4.2.1. Peramivir Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.3. Zanamivir
                        4.3.1. Zanamivir Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Baloxavir Marboxil
                        4.4.1. Baloxavir Marboxil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Oseltamivir Phosphate
                        4.5.1. Oseltamivir Phosphate Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Others
                        4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Influenza Treatment Market: Route of Administration Estimates & Trend Analysis
                    5.1. Influenza Treatment Market: Route of Administration Movement Analysis
                    5.2. Oral
                        5.2.1. Oral Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.3. Others
                        5.3.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Influenza Treatment Market: Distribution Channel Estimates & Trend Analysis
                    6.1. Influenza Treatment Market: Distribution Channel Movement Analysis
                    6.2. Hospital Pharmacies
                        6.2.1. Hospital Pharmacies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.3. Retail Pharmacies
                        6.3.1. Retail Pharmacies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Online Pharmacies
                        6.4.1. Online Pharmacies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Influenza Treatment Market: Regional Business Analysis
                    7.1. Regional Market Snapshot
                    7.2. North America
                        7.2.1. North America Influenza Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
                        7.2.2. U.S.
                            7.2.2.1. U.S. Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.2.2.2. Key Country Dynamics
                            7.2.2.3. Regulatory Framework
                            7.2.2.4. Reimbursement Scenario
                            7.2.2.5. Competitive Scenario
                        7.2.3. Canada
                            7.2.3.1. Canada Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.2.3.2. Key Country Dynamics
                            7.2.3.3. Regulatory Framework
                            7.2.3.4. Reimbursement Scenario
                            7.2.3.5. Competitive Scenario
                    7.3. Europe
                        7.3.1. Europe Influenza Treatment Market, 2018 - 2030 (USD Million)
                        7.3.2. UK
                            7.3.2.1. UK Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.2.2. Key Country Dynamics
                            7.3.2.3. Regulatory Framework
                            7.3.2.4. Reimbursement Scenario
                            7.3.2.5. Competitive Scenario
                        7.3.3. Germany
                            7.3.3.1. Germany Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.3.2. Key Country Dynamics
                            7.3.3.3. Regulatory Framework
                            7.3.3.4. Reimbursement Scenario
                            7.3.3.5. Competitive Scenario
                        7.3.4. France
                            7.3.4.1. France Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.4.2. Key Country Dynamics
                            7.3.4.3. Regulatory Framework
                            7.3.4.4. Reimbursement Scenario
                            7.3.4.5. Competitive Scenario
                        7.3.5. Italy
                            7.3.5.1. Italy Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.5.2. Key Country Dynamics
                            7.3.5.3. Regulatory Framework
                            7.3.5.4. Reimbursement Scenario
                            7.3.5.5. Competitive Scenario
                        7.3.6. Spain
                            7.3.6.1. Spain Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.6.2. Key Country Dynamics
                            7.3.6.3. Regulatory Framework
                            7.3.6.4. Reimbursement Scenario
                            7.3.6.5. Competitive Scenario
                        7.3.7. Denmark
                            7.3.7.1. Denmark Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.7.2. Key Country Dynamics
                            7.3.7.3. Regulatory Framework
                            7.3.7.4. Reimbursement Scenario
                            7.3.7.5. Competitive Scenario
                        7.3.8. Norway
                            7.3.8.1. Norway Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.8.2. Key Country Dynamics
                            7.3.8.3. Regulatory Framework
                            7.3.8.4. Reimbursement Scenario
                            7.3.8.5. Competitive Scenario
                        7.3.9. Sweden
                            7.3.9.1. Sweden Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.3.9.2. Key Country Dynamics
                            7.3.9.3. Regulatory Framework
                            7.3.9.4. Reimbursement Scenario
                            7.3.9.5. Competitive Scenario
                    7.4. Asia Pacific
                        7.4.1. Asia-pacific Influenza Treatment Market, 2018 - 2030 (USD Million)
                        7.4.2. Japan
                            7.4.2.1. Japan Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.2.2. Key Country Dynamics
                            7.4.2.3. Regulatory Framework
                            7.4.2.4. Reimbursement Scenario
                            7.4.2.5. Competitive Scenario
                        7.4.3. China
                            7.4.3.1. China Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.3.2. Key Country Dynamics
                            7.4.3.3. Regulatory Framework
                            7.4.3.4. Reimbursement Scenario
                            7.4.3.5. Competitive Scenario
                        7.4.4. India
                            7.4.4.1. India Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.4.2. Key Country Dynamics
                            7.4.4.3. Regulatory Framework
                            7.4.4.4. Reimbursement Scenario
                            7.4.4.5. Competitive Scenario
                        7.4.5. South Korea
                            7.4.5.1. South Korea Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.5.2. Key Country Dynamics
                            7.4.5.3. Regulatory Framework
                            7.4.5.4. Reimbursement Scenario
                            7.4.5.5. Competitive Scenario
                        7.4.6. Australia
                            7.4.6.1. Australia Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.6.2. Key Country Dynamics
                            7.4.6.3. Regulatory Framework
                            7.4.6.4. Reimbursement Scenario
                            7.4.6.5. Competitive Scenario
                        7.4.7. Thailand
                            7.4.7.1. Thailand Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.4.7.2. Key Country Dynamics
                            7.4.7.3. Regulatory Framework
                            7.4.7.4. Reimbursement Scenario
                            7.4.7.5. Competitive Scenario
                    7.5. Latin America
                        7.5.1. Latin America Influenza Treatment Market, 2018 - 2030 (USD Million)
                        7.5.2. Brazil
                            7.5.2.1. Brazil Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.5.2.2. Key Country Dynamics
                            7.5.2.3. Regulatory Framework
                            7.5.2.4. Reimbursement Scenario
                            7.5.2.5. Competitive Scenario
                        7.5.3. Mexico
                            7.5.3.1. Mexico Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.5.3.2. Key Country Dynamics
                            7.5.3.3. Regulatory Framework
                            7.5.3.4. Reimbursement Scenario
                            7.5.3.5. Competitive Scenario
                        7.5.4. Argentina
                            7.5.4.1. Argentina Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.5.4.2. Key Country Dynamics
                            7.5.4.3. Regulatory Framework
                            7.5.4.4. Reimbursement Scenario
                            7.5.4.5. Competitive Scenario
                    7.6. MEA
                        7.6.1. MEA Influenza Treatment Market, 2018 - 2030 (USD Million)
                        7.6.2. South Africa
                            7.6.2.1. South Africa Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.6.2.2. Key Country Dynamics
                            7.6.2.3. Regulatory Framework
                            7.6.2.4. Reimbursement Scenario
                            7.6.2.5. Competitive Scenario
                        7.6.3. Saudi Arabia
                            7.6.3.1. Saudi Arabia Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.6.3.2. Key Country Dynamics
                            7.6.3.3. Regulatory Framework
                            7.6.3.4. Reimbursement Scenario
                            7.6.3.5. Competitive Scenario
                        7.6.4. UAE
                            7.6.4.1. UAE Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.6.4.2. Key Country Dynamics
                            7.6.4.3. Regulatory Framework
                            7.6.4.4. Reimbursement Scenario
                            7.6.4.5. Competitive Scenario
                        7.6.5. Kuwait
                            7.6.5.1. Kuwait Influenza Treatment Market, 2018 - 2030 (USD Million)
                            7.6.5.2. Key Country Dynamics
                            7.6.5.3. Regulatory Framework
                            7.6.5.4. Reimbursement Scenario
                            7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Strategy Mapping
                        8.2.1. New Launch
                        8.2.2. Partnerships
                        8.2.3. Acquisition
                        8.2.4. Collaboration
                    8.3. Key Company Market Share Analysis, 2023
                    8.4. Company Heat Map Analysis
                    8.5. Company Profiles
                        8.5.1. Natco Pharma Limited
                            8.5.1.1. Company Overview
                            8.5.1.2. Financial Performance
                            8.5.1.3. Product Benchmarking
                            8.5.1.4. Strategic Initiatives
                        8.5.2. Novartis Ag
                            8.5.2.1. Company Overview
                            8.5.2.2. Financial Performance
                            8.5.2.3. Product Benchmarking
                            8.5.2.4. Strategic Initiatives
                        8.5.3. F. Hoffmann-la Roche Ltd
                            8.5.3.1. Company Overview
                            8.5.3.2. Financial Performance
                            8.5.3.3. Product Benchmarking
                            8.5.3.4. Strategic Initiatives
                        8.5.4. Biocryst Pharmaceuticals, Inc.
                            8.5.4.1. Company Overview
                            8.5.4.2. Financial Performance
                            8.5.4.3. Product Benchmarking
                            8.5.4.4. Strategic Initiatives
                        8.5.5. Sanofi
                            8.5.5.1. Company Overview
                            8.5.5.2. Financial Performance
                            8.5.5.3. Product Benchmarking
                            8.5.5.4. Strategic Initiatives
                        8.5.6. Gsk Plc.
                            8.5.6.1. Company Overview
                            8.5.6.2. Financial Performance
                            8.5.6.3. Product Benchmarking
                            8.5.6.4. Strategic Initiatives
                        8.5.7. Viatris Inc. (Mylan)
                            8.5.7.1. Company Overview
                            8.5.7.2. Financial Performance
                            8.5.7.3. Product Benchmarking
                            8.5.7.4. Strategic Initiatives
                        8.5.8. Teva Pharmaceutical Industries Ltd.
                            8.5.8.1. Company Overview
                            8.5.8.2. Financial Performance
                            8.5.8.3. Product Benchmarking
                            8.5.8.4. Strategic Initiatives
                        8.5.9. Daiichi Sankyo Company, Limited.
                            8.5.9.1. Company Overview
                            8.5.9.2. Financial Performance
                            8.5.9.3. Product Benchmarking
                            8.5.9.4. Strategic Initiatives
                        8.5.10. Astrazeneca
                            8.5.10.1. Company Overview
                            8.5.10.2. Financial Performance
                            8.5.10.3. Product Benchmarking
                            8.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Influenza Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 4 North America Influenza Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 5 North America Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 6 North America Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 7 North America Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 U.S. Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 9 U.S. Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 10 U.S. Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 Canada Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 12 Canada Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 Canada Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Europe Influenza Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 15 Europe Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 16 Europe Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 17 Europe Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Germany Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 19 Germany Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 20 Germany Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 UK Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 22 UK Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 23 UK Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 France Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 25 France Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 France Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Spain Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 28 Spain Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 29 Spain Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 30 Italy Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 31 Italy Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 32 Italy Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Denmark Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 34 Denmark Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Denmark Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Norway Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 37 Norway Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 38 Norway Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Sweden Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 40 Sweden Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 41 Sweden Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Influenza Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Japan Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 47 Japan Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 48 Japan Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 49 China Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 50 China Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 China Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 India Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 53 India Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 54 India Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Australia Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 56 Australia Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 57 Australia Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 South Korea Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 59 South Korea Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 60 South Korea Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 61 Thailand Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 62 Thailand Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Thailand Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Latin America Influenza Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 65 Latin America Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 66 Latin America Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Latin America Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Brazil Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 69 Brazil Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 Brazil Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 71 Mexico Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 72 Mexico Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 73 Mexico Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 74 Argentina Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 75 Argentina Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 Argentina Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa Influenza Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 South Africa Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 85 South Africa Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 South Africa Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 87 UAE Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 88 UAE Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 89 UAE Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 90 Kuwait Influenza Treatment Market, By Treatment, 2018 - 2030 (USD Million)
Table 91 Kuwait Influenza Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 92 Kuwait Influenza Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global influenza treatment market- Key market driver analysis
Fig. 7 Global influenza treatment market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global influenza treatment market - Porter’s analysis
Fig. 10 Global influenza treatment market - PESTEL analysis
Fig. 11 Global influenza treatment market: Treatment outlook key takeaways
Fig. 12 Global influenza treatment market: Treatment movement analysis
Fig. 13 Peramivir market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Zanamivir market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Baloxavir marboxil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Oseltamivir phosphate market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Global influenza treatment market: Route of Administration outlook key takeaways
Fig. 19 Global influenza treatment market: Route of Administration movement analysis
Fig. 20 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Global influenza treatment market: Distribution Channel outlook key takeaways
Fig. 23 Global influenza treatment market: Distribution Channel movement analysis
Fig. 24 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Global influenza treatment market: Regional movement analysis
Fig. 29 North America influenza treatment market, 2018 - 2030 (USD Million)
Fig. 30 U.S. influenza treatment market, 2018 - 2030 (USD Million)
Fig. 31 Canada influenza treatment market, 2018 - 2030 (USD Million)
Fig. 32 Europe influenza treatment market, 2018 - 2030 (USD Million)
Fig. 33 UK influenza treatment market, 2018 - 2030 (USD Million)
Fig. 34 Germany influenza treatment market, 2018 - 2030 (USD Million)
Fig. 35 France influenza treatment market, 2018 - 2030 (USD Million)
Fig. 36 Italy influenza treatment market, 2018 - 2030 (USD Million)
Fig. 37 Spain influenza treatment market, 2018 - 2030 (USD Million)
Fig. 38 Denmark influenza treatment market, 2018 - 2030 (USD Million)
Fig. 39 Norway influenza treatment market, 2018 - 2030 (USD Million)
Fig. 40 Sweden influenza treatment market, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific influenza treatment market, 2018 - 2030 (USD Million)
Fig. 42 Japan influenza treatment market, 2018 - 2030 (USD Million)
Fig. 43 China influenza treatment market, 2018 - 2030 (USD Million)
Fig. 44 India influenza treatment market, 2018 - 2030 (USD Million)
Fig. 45 South Korea influenza treatment market, 2018 - 2030 (USD Million)
Fig. 46 Australia influenza treatment market, 2018 - 2030 (USD Million)
Fig. 47 Thailand influenza treatment market, 2018 - 2030 (USD Million)
Fig. 48 Latin America influenza treatment market, 2018 - 2030 (USD Million)
Fig. 49 Brazil influenza treatment market, 2018 - 2030 (USD Million)
Fig. 50 Mexico influenza treatment market, 2018 - 2030 (USD Million)
Fig. 51 Argentina influenza treatment market, 2018 - 2030 (USD Million)
Fig. 52 MEA influenza treatment market, 2018 - 2030 (USD Million)
Fig. 53 South Africa influenza treatment market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia influenza treatment market, 2018 - 2030 (USD Million)
Fig. 55 UAE influenza treatment market, 2018 - 2030 (USD Million)
Fig. 56 Kuwait influenza treatment market, 2018 - 2030 (USD Million)
Fig. 57 Strategy framework